(Q37808970)

23 August 2017

title

Insulin analogues in the management of the pregnancy complicated by diabetes mellitus (English)

1 reference

23 August 2017

Insulin Analogues in the Management of the Pregnancy Complicated by Diabetes Mellitus (English)

1 reference

https://api.crossref.org/works/10.1007/S11892-010-0160-0

25 August 2024

0 references

1 reference

Celeste P. Durnwald

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21072620

25 August 2024

Mark B. Landon

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21072620

25 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21072620

25 August 2024

publication date

1 February 2011

1 reference

full work available at URL

23 August 2017

http://www.current-reports.com/1534-4827/11/28

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21072620

http://link.springer.com/content/pdf/10.1007/s11892-010-0160-0.pdf

25 August 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S11892-010-0160-0

http://link.springer.com/article/10.1007/s11892-010-0160-0/fulltext.html

25 August 2024

1 reference

https://api.crossref.org/works/10.1007/S11892-010-0160-0

http://link.springer.com/content/pdf/10.1007/s11892-010-0160-0

25 August 2024

1 reference

https://api.crossref.org/works/10.1007/S11892-010-0160-0

25 August 2024

published in

Current diabetes report

1 reference

23 August 2017

volume

11

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

28-34

1 reference

Glycemic control in gestational diabetes mellitus--how tight is tight enough: small for gestational age versus large for gestational age?

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development--Diabetes in Early Pregnancy Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Neonatal morbidity in pregnancy complicated by diabetes mellitus: predictive value of maternal glycemic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Pregestational diabetes: insulin requirements throughout pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Metabolic and immunologic effects of insulin lispro in gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Transfer of insulin lispro across the human placenta: in vitro perfusion studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Is insulin lispro safe in pregnant women: Does it cause any adverse outcomes on infants or mothers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Survey of glargine use in 115 pregnant women with Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Use of insulin glargine throughout pregnancy in 102 women with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Insulin glargine safety in pregnancy: a transplacental transfer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Insulin glargine versus neutral protamine Hagedorn insulin for treatment of diabetes in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0160-0

Preconception care of diabetes. Glycemic control prevents congenital anomalies

21 January 2018

1 reference

12 December 2020

Use of insulin detemir in pregnancy: a report on 10 Type 1 diabetic women

1 reference

12 December 2020

Insulin Lispro in pregnancy--retrospective analysis of 33 cases and matched controls

1 reference

12 December 2020

Preliminary experience with the use of insulin lispro in pregnant diabetic women

1 reference

12 December 2020

Transfer of insulin lispro across the human placenta

1 reference

12 December 2020

Insulin lispro and regular insulin in pregnancy

1 reference

12 December 2020

Pregnancy complications and perinatal outcome in diabetic women treated with Humalog (insulin lispro) or regular human insulin during pregnancy

1 reference

12 December 2020

Is insulin lispro associated with the development or progression of diabetic retinopathy during pregnancy?

1 reference

12 December 2020

The relationship between large-for-gestational-age infants and glycemic control in women with gestational diabetes

1 reference

12 December 2020

Insulin glargine compared with Neutral Protamine Hagedorn insulin in the treatment of pregnant diabetics

1 reference

12 December 2020

Use of Insulin Glargine During the First Weeks of Pregnancy in Five Type 1 Diabetic Women

1 reference

12 December 2020

Perinatal outcomes in pregnancies managed with antenatal insulin glargine

1 reference

12 December 2020

A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy

1 reference

12 December 2020

Use of glargine insulin before and during pregnancy in a woman with type 1 diabetes and Addison's Disease

1 reference

12 December 2020

Use of insulin glargine during embryogenesis in a pregnant woman with Type 1 diabetes

1 reference

12 December 2020

Successful use of insulin glargine during entire pregnancy until delivery in six Type 1 diabetic women

1 reference

12 December 2020

Evaluation of insulin antibodies and placental transfer of insulin aspart in pregnant women with type 1 diabetes mellitus

1 reference

12 December 2020

Possible adverse fetal effect of insulin lispro

1 reference

12 December 2020

Glargine vs. NPH insulin therapy in pregnancies complicated by diabetes: an observational cohort study

1 reference

12 December 2020

Use of insulin detemir during pregnancy

1 reference

12 December 2020

Insulin lispro, pregnancy, and retinopathy

1 reference

12 December 2020

Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy

1 reference

12 December 2020

Medical Science Monitor

15

10

PI29

K Cypryk

2004

1 reference

https://api.crossref.org/works/10.1007/S11892-010-0160-0

Diabetes mellitus may be the earliest and sole manifestation of the H syndrome

25 August 2024

series ordinal

44

1 reference

https://api.crossref.org/works/10.1007/S11892-010-0160-0

25 August 2024

Identifiers

1 reference

23 August 2017

1 reference